SAN ANTONIO (PRWEB)
October 09, 2019

As a dedicated leader in the clinical trial industry, RealTime Software Solutions is pleased to announce that they have joined the Society for Clinical Research Sites Global Impact Partner (GIP) Program.

RealTime CEO Rick Greenfield, a long-time member of SCRS, says the partnership is just another way for the company to come together with industry leaders to help streamline the way research is done.

“As a long-time attendee of the Site Solutions Summit and proud member of SCRS, I have seen first-hand the difference that SCRS has made for clinical research sites and the research industry as a whole,” says Greenfield. “I could not be prouder to bring RealTime into the GIP family at SCRS and to join the cause for better processes, systems and best practices that will improve the clinical research landscape for Sites, CROs and Sponsors alike. At RealTime, we prioritize the needs of the industry so we can offer solutions that truly make a difference. The GIP program gives us the opportunity to listen and contribute on a whole new level.”

As a member of GIP, RealTime will have the opportunity to work directly with major players in all facets of the clinical research industry to include large-scale CROs, data vendors, service providers, sites and site networks that all have a hand in shaping clinical research.

Members also benefit by having a seat on the GIP board which interfaces with SCRS leadership to set strategic initiatives for the Society. SCRS GIP members may also elect to engage the SCRS community for individual corporate objectives using SCRS program options that include focus groups, surveys, research, content development, and geographic or regional site support.

To learn more about RealTime Software Solutions, visit RealTime-CTMS.com.

About RealTime Software Solutions

Founded in February of 2013, RealTime Software Solutions, LLC strives to bring innovative Clinical Trial Management Systems (CTMS) to sites, CROs and sponsors of all shapes and sizes. The core values of RealTime include, “Innovation Now”, “Think Like Customers” and “Integrity Always”. These values have helped RealTime grow into a leading CTMS provider for systems like SitePAY, GlobalPAY, eDOCS and eSOURCE for thousands of customers around the world. RealTime will continue the pursuit of advanced systems and processes that enhance the workflow and efficiency of all stakeholders within the clinical research execution process. Visit RealTime-CTMS.com to learn more.

Share article on social media or email:

ISACS 2019

I hope more people be aware of the importance of bone health and the available solutions for their bodies.

VANCOUVER, British Columbia (PRWEB)
October 09, 2019

Calcium & Bone Health Institute (CBHI) held International Sigma Anti-Bonding Calcium Symposium (ISACS) 2019 at Executive Plaza Hotel in Vancouver, Canada on September 23-24 for two days. The purpose of symposium was to discuss and share the knowledge of the various measures to develop healthy bone and to prevent calcium-related diseases. The theme of this year was “The Secret of Reversible Bone Health”.

“While serving as the president of CBHI which conducts intensive research about the significance of calcium for the human body, I thought of a place where researchers and professors come together to share their knowledge and create synergy effect in their research field,” said Dr. Paul Lee, the ISACS Chair. “I am very grateful that we could start the first Symposium in Vancouver, Canada. I hope more people be aware of the importance of bone health and the available solutions for their bodies.”

The speakers included researchers, professors, dentists, pharmacists, businessmen and patients. People from U.S.A., Canada, Korea, China, Indonesia, and Japan attended in the event. The topics by speakers ranged from cancer, bone, dental treatment, and arrhythmias, to diabetes. Testimonials by patients with SAC treatment were also presented.

SAC (Sigma Anti-Bonding Calcium) calcium was invented by Dr. Paul Lee in 2009. The atomic orbitals of SAC calcium molecule have sigma anti-bonding and therefore, easily separated into atoms in the water, absorbed in the body in the ionic form, Ca++. It is 200 times more soluble in water and has shown up to 80% bone mineral density increase in thousands of people. SAC calcium awakens body’s dormant response and the process is fully natural without side effect.

As the first ISACS 2019 was successfully held, CBHI plans to hold the event internationally following years.

About CBHI

Calcium and Bone Health Institute (CBHI) is Canada based research organization that has invented Sigma Anti-bonding Calcium (SAC). It has partnership with many universities and research organizations. Its invented SAC calcium was tried by thousands of people with great responses from their bodies. It continues to research on many challenging diseases such as osteoporosis, cancer, stem cell, diabetes, Alzheimer’s disease and more.

Share article on social media or email:

SAN FRANCISCO (PRWEB)
October 09, 2019

Today, Better Therapeutics, a company developing prescription digital therapeutics for the treatment of cardiometabolic diseases, announced the publication of its fifth peer-reviewed study titled Estimating the impact of novel digital therapeutics in type 2 diabetes and hypertension: Health economic analysis.

“Chronic diseases including diabetes and heart disease affect half of all adults in the US and account for nearly 80 cents of every healthcare dollar spent. Digital therapeutics that deliver behavioral interventions focused on lifestyle demonstrate potential benefits over traditional therapies like medications and surgeries that treat the effects of disease while leaving the causes in place. They can increase patient access because they are inherently scalable, continuously delivered, and have demonstrated both clinical and cost-effectiveness in diabetes and hypertension,” said Kevin Appelbaum, CEO and study co-author.

The economic analysis estimated cost savings of $145 per patient per month (PPPM) in diabetes, and $97 PPPM in hypertension. These savings are realized by addressing the behaviors and lifestyle factors that are the root causes of disease, reducing the ongoing need for prescription medications. The potential cost savings increases substantially (30-60%) in moderately severe to severe patient populations. The intervention would be cost-effective at total three-year program costs of $6,468 for diabetes and $6,620 for hypertension.

Read the complete study here.

“Our analysis concluded that Better’s digital therapeutics for diabetic and hypertensive patients may provide substantial improvements in patient outcomes resulting in lower health resource utilization and costs, mostly resulting from decreased need for medications,” said health economist and lead author, Bob Nordyke, PhD.

About Better Therapeutics

Better develops prescription software for treating cardiometabolic diseases. By integrating elements of neuroscience, lifestyle medicine, and artificial intelligence, the company has created a new modality for treating a broad range of conditions that share common root causes. The company’s digital therapeutics have been validated in peer-reviewed and published clinical trials. Better is commercializing its disease reversal program with health plans, while pursuing regulatory approval of its first prescription digital therapeutic for treating type 2 diabetes. The company is headquartered in San Francisco, CA, and is a member of the Digital Therapeutics Alliance.

Share article on social media or email:

NEW YORK (PRWEB)
October 13, 2019

Fruit Street Health, a digital health and telemedicine company, announced today that its platform has been selected by a research team at Brigham and Women’s Hospital (BWH), an affiliate of Harvard Medical School and a founding member of Partners HealthCare, to study different ways to improve brain healthy behaviors in individuals at risk for cognitive decline and dementia.

Over 5.8 million people in the United States alone have Alzheimer disease or related dementias (ADRDs), conditions which carry vast economic, societal, and personal burdens for health systems and families. Research has shown that up to 1/3 of the risk of ADRDs may be reduced by adopting brain healthy behaviors, including aerobic exercise, a Mediterranean diet, and engaging in socially and cognitively stimulating activities. Even while significant pharmaceutical research continues in efforts to delay or prevent dementia, the medical community, today, has evidence that lifestyle interventions are effective at reducing risk, in addition to having myriad benefits to overall health. “There is a giant gap between our knowledge of the behaviors that reduce dementia risk and our application of this knowledge in the delivery of care” said Dr. Seth Gale, investigator and neurologist at Brigham and Women’s Hospital.

Neurologists and primary care providers at the Brigham are planning a 6-month pilot study of older patients who are at a higher risk for dementia compared to their peers. Health coaches, allied with study participants’ providers, will employ Fruit Street’s digital platform to educate and motivate participants to achieve positive changes in brain healthy behaviors. In the study, coaches will take advantage of the platform’s fitness activity tracking, photographing of dietary intake, and two-way video and mobile messaging to guide participants in reaching individualized lifestyle goals. Measures of quality of life, sleep, cognitive function, physical activity, and diet among others, will be tracked over the 6-month study.

“We are excited to be contributing to this effort at Brigham and Women’s, where technology will be used directly to study the implementation of treatment recommendations,” said Laurence Girard, CEO of Fruit Street Health. “Dementia is a major public health burden and we are committed to finding innovative ways to help fight it.”

Fruit Street Health is a digital health and telemedicine company which currently licenses its software to healthcare professionals who wish to set up a virtual practice. It was the first company to deliver the Center for Disease Control & Prevention’s (CDC’s) National Diabetes Prevention Program (“DPP”), which has complimentary goals to those in the dementia risk reduction study being planned at BWH. Fruit Street’s HIPAA-compliant telehealth software is possible through a joint venture agreement with VSee, the world’s largest telemedicine video engine with more than three million users. Fruit Street and VSee collaborated to build a telemedicine product that helps healthcare providers conduct HIPAA compliant video calls and monitor the diet and lifestyle of patients using wearable devices and mobile applications. VSee is considered the gold standard for HIPAA compliant video conferencing in the telemedicine industry and offers the most bandwidth efficient video software in the world.

Share article on social media or email:

TAMPA, Fla. (PRWEB)
October 09, 2019

Benzer Pharmacy, a fast-growing chain of independent pharmacies headquartered in Tampa Bay, continues to turn its expansion efforts in a northbound-75 direction, now proudly welcoming a new store to its franchise family in Ohio—one located on W Town St./U.S. Highway 62 in Columbus.

Company officials have announced plans to hold an onsite grand opening celebration, including food and refreshments, kicking off at 9am on Wednesday, October 9th with an honorary ribbon-cutting ceremony to follow within the hour at 9:45am. Benzer notables Vinesh Darji, President of Benzer Franchise; and Tony Marakas, Vice President, will be on-hand to lead the proceedings, as joined by members of the Columbus Chamber.

For his part, Darji looks forward to the occasion being a memorable one as it represents another big step forward in “the biggest small town in America.”

“The more people learn about Benzer Pharmacy, the more there is to like,” Darji said. “This event gives us the perfect opportunity to spread the word about the brand and the benefits it brings to the table—things like free home delivery, shorter prescription-fill times of just 5-10 minutes on average, and the most competitive prices in town.”

Marakas continued, “Even better, Benzer offers free blister packaging, refill synchronization, and other customized medication pick-up options, as well as a host of clinical services ranging from medication therapy management and immunizations to diabetic consultation, smoking cessation support, and blood pressure screening, to name just a few.”

The new store will be led by veteran retail manager and store owner Tom Mox; and pharmacist-in-charge Terry Malone, a practicing pharmacist in central Ohio for the last 37 years.

“Both Tom and Terry share the Benzer commitment toward outstanding service with a strong emphasis on patient care and driving improvement in outcomes,” Darji explained. “Having them onboard will make all the difference in establishing a presence for the organization in Columbus that’s here today, and here to stay.”

The new Benzer Pharmacy Franchise will be open for business weekdays from 9am to 5pm, located at 867 W Town St., #103-104 in Columbus, Ohio 43222. Customers may reach the pharmacy by phone at 614-725-1340; Fax: 202-991-2612. All major insurances accepted.

For more information about Benzer Pharmacy, visit http://www.benzerpharmacy.com. To find a location nearest you, log on to http://www.benzerpharmacy.com/find-a-store/

###

About Benzer Pharmacy. Founded in 2009, Benzer Pharmacy is a chain of independent retail pharmacies specializing in compounding and specialty medication. Currently, there are 82 corporate-owned and 34 franchise locations situated throughout 29 states, including Florida, Michigan, Virginia, West Virginia, North Carolina, Tennessee, Texas, Georgia, Nevada, Louisiana, New York, Missouri, Mississippi, Maryland, Ohio, Indiana, and Idaho. Projections call for continued rapid growth as the organization seeks to substantially increase its customer base, while ensuring experiences match expectations at every touchpoint.

Benzer Pharmacy has made four straight appearances on Inc. 5,000 list of the fastest growing private companies in America from 2015-2018; correspondingly, the company earned 39th place on the 2015 Florida Fast 100 list, while concurrently placing 67th on the 2015 TBBJ 200 list of Tampa Bay’s largest private companies. Benzer was also voted favorite pharmacy in the 2015 Best of Fuquay Varina in North Carolina, and achieved PCAB compounding accreditation with Accreditation Commission for Health Care (ACHC). All Benzer Pharmacy medications require a doctor’s prescription.

Facebook: https://www.facebook.com/BenzerPharmacyFranchise/

LinkedIn: https://www.linkedin.com/company/benzer-pharmacy-franchising-llc/

SOURCE: Benzer Franchise

Share article on social media or email:

COLUMBUS, Ohio (PRWEB)
October 10, 2019

A growing team at FrazierHeiby, a Columbus-based marketing communications consultancy, has expanded its client roster with additions from the healthcare, insurance and high-tech industries.

“This is an exciting time for our business,” said Lauren Parker, executive vice president of FrazierHeiby. “The market is hungry for intelligent communications consultation that blends insight-led strategy with impeccable tactical execution. We’re investing in our business so we can provide the highest level of service to our clients and we’re already seeing positive results.”

St. Elizabeth Healthcare — one of the oldest, largest and most respected medical providers in the Greater Cincinnati/Northern Kentucky region — hired FrazierHeiby as its agency of record to lead national media, influencer relations and communications strategy.

“After a national search for an integrated strategic communication and public relations agency partner, we were pleased to select FrazierHeiby as our agency of record,” shared Sarah Wice-Courtney, director of communications and public relations for St. Elizabeth Healthcare. “Our organization is in an exciting time of innovative transformation of services and patient care. FrazierHeiby displayed a deep understanding of our strategic priorities and where we want to drive our brand and media presence both regionally and nationally.”

The leading association for independent insurance agents in the state, Ohio Insurance Agents (OIA), tapped the team to lead strategic branding, website development and member engagement programming. Its chief marketing officer Jody Geiger noted, “With three firms in the running, we decided to entrust FrazierHeiby with our business due to their quick understanding of the complexities of our business and their thoughtful approach to solving our marketing challenges. I have deep respect for how the team leverages research and data to guide everything they do. We’re excited to continue our relationship with FrazierHeiby to elevate the OIA brand at the state and national level.”

Additionally, FrazierHeiby established a relationship with Silfex, the world’s largest provider of high-purity custom silicon components for the solar, optics and semiconductor markets. The team will lead internal and external communications projects for the Springfield, Ohio-based organization.

To ensure it delivers the highest quality of service to its clients, the agency has also brought on new senior talent. Kim Ratcliff, APR, brings more than two decades of experience as a business analyst and strategic communicator with a deep understanding of the education, healthcare, technology and non-profit fields. She will play a senior role across the agency’s largest accounts.

“Kim truly embodies the future of our organization,” said Parker. “She’s smart, data-driven and results-oriented. We’re extremely lucky to have her on our team.”

About FrazierHeiby

FrazierHeiby is an independent marketing communications agency based in Columbus, Ohio. In operation since 1983, the team of curious minds, creative thinkers and collaborative partners serves brands and organizations that propel the economy, including energy/utility, agriculture, healthcare, manufacturing, professional services and economic development. Services include strategic planning, branding and positioning, public relations, social media, marketing services, content, crisis and reputation management, employee engagement, creative design and measurement. For more information, please visit http://www.fhcommunicate.com.

Share article on social media or email:

WASHINGTON (PRWEB)
October 10, 2019

WEDI, the nation’s leading nonprofit authority on the use of health IT to create efficiencies in health care information exchange and a statutory advisor to the U.S. Department of Health and Human Services (HHS), today announced the development of an industry white paper that provides a baseline understanding of various purposes of health care encounter transactions, their processing models and definitions.

According to the paper, “Health care encounter transactions have generally been thought of as secondary use of claims data; data that is used for research and public health surveillance. As alternative payment models and value-based care gain traction, health care encounter transactions and the use of that data have become more prevalent and meaningful. The industry needs to understand the current uses and transmissions of health care encounter data in order to address the barriers and variances that exist today.”

The 32-page document addresses the longstanding purposes, meanings, and needs related to the use and processes associated with health care encounter transactions. Some key takeaways from the white paper’s conclusion include:

• 
  The industry needs to understand the current uses and transmissions of health care encounter data in order to address the barriers and variances that exist today.
• Encounter data is sent and received by different organizations. Although the entities involved in sending and receiving the encounter data and transmission methods are similar, each model has its own intent for why the data is being transmitted and what needs to be transmitted.
• Various nonstandard and work-around methods are used today to send and receive data that are not accommodated in current standard transactions.

For more information on WEDI’s industry efforts surrounding Provider Adjustments, please visit the WEDI Claims Subworkgroup page.

About WEDI

WEDI is the leading authority on the use of health IT to improve health care information exchange in order to enhance the quality of care, improve efficiency, and reduce costs of our nation’s health care system. WEDI was formed in 1991 by the Secretary of Health and Human Services and was designated in the 1996 HIPAA legislation as an advisor to HHS. WEDI’s membership includes a broad coalition of organizations, including: hospitals, providers, health plans, vendors, government agencies, consumers, not-for-profit organizations, and standards development organizations. To learn more, visit http://www.wedi.org and connect with us on Twitter and LinkedIn.

Share article on social media or email: